Editorial Dermatology Hematology
Pharmacist-led medication review and medication adherence in pregnant women: A prospective cohort study

Pharmacist-led medication review and medication adherence in pregnant women: A prospective cohort study

Authors

Yusuf Silva

Yusuf Silva

Hamad Medical Corporation, Iran

Sofia Osei

Sofia Osei

Aga Khan University Hospital, Lesotho

Clara Tanaka

Clara Tanaka

Toronto General Hospital, Liberia

Corresponding
Malik Ahmed

Malik Ahmed

Aga Khan University Hospital, French Guiana

Malik Rossi

Malik Rossi

Mayo Clinic, New Zealand

Published

October 26, 2025

Paper ID

PAP-000061

Status

Published

DOI

10.65712/tmj.test000319

Pharmacist-led medication review and medication adherence in pregnant women: A prospective cohort study

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Earlier studies of pharmacist-led medication review were small or single-centre. Methods: Eligible participants were pregnant women. Results: Effects were consistent across prespecified subgroups. Effects were consistent across prespecified subgroups. Conclusion: Strengths include the sample size and blinded outcome assessment.

References

1. Zhang B, Tanaka Y, et al. Home-based cardiac rehabilitation and length of stay. JAMA. 2025;139(8):318-1261.

2. Yilmaz C, Tanaka B, et al. Prone positioning and 30-day readmission. N Engl J Med. 2021;22(9):842-1659.

3. Herrera Z, Costa Q, et al. Telemedicine follow-up and acute kidney injury. BMC Med. 2011;309(3):383-1666.

4. Kowalski P, Kaur U, et al. Low-dose aspirin and time to diagnosis. Lancet. 2014;339(3):240-1079.

5. Volkov G, Novak Y, et al. Home-based cardiac rehabilitation and patient satisfaction. Ann Intern Med. 2018;163(5):591-938.

6. Ahmed H, Haddad F, et al. Prone positioning and in-hospital mortality. Lancet. 2016;244(12):17-1173.

7. Yilmaz V, Patel R, et al. Machine-learning triage and glycaemic control. BMJ. 2025;51(8):321-1777.

8. Kowalski Y, Moreau P, et al. Delayed cord clamping and in-hospital mortality. Lancet. 2009;188(9):179-1126.

Introduction

Earlier studies of pharmacist-led medication review were small or single-centre. medication adherence remains a leading cause of avoidable harm among pregnant women. Practice around pharmacist-led medication review varies widely between centres.

medication adherence remains a leading cause of avoidable harm among pregnant women. The cost of medication adherence to health systems is substantial. Earlier studies of pharmacist-led medication review were small or single-centre.

medication adherence remains a leading cause of avoidable harm among pregnant women. Guidelines make only a weak recommendation on pharmacist-led medication review.

medication adherence remains a leading cause of avoidable harm among pregnant women. Practice around pharmacist-led medication review varies widely between centres.

Materials and Methods

Analyses were adjusted for age, sex and baseline severity. We conducted a prospective cohort study across 9 centres between 2017 and 2023. We conducted a prospective cohort study across 6 centres between 2019 and 2021.

The primary outcome was medication adherence, assessed blind to allocation. We conducted a prospective cohort study across 5 centres between 2017 and 2025.

Results

medication adherence occurred in 22% of the intervention group versus 14% of controls. 2895 participants were included (median age 53 years). 4235 participants were included (median age 50 years).

GroupnEvents
Control48956
Age < 6557726
Centre B60224
TABLE 1: Adverse events
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in medication adherence
Shown for pregnant women; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Distribution of medication adherence
Shown for pregnant women; error bars are 95% confidence intervals.

897 participants were included (median age 35 years). medication adherence occurred in 14% of the intervention group versus 30% of controls.

Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.69 (95% CI 0.40 to 0.92). The adjusted odds ratio was 0.38 (95% CI 0.32 to 0.72).

Discussion

These findings suggest that pharmacist-led medication review is associated with better medication adherence in pregnant women. Implementation will depend on staffing, cost and local protocols.

Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

Future work should test pharmacist-led medication review in a pragmatic multicentre trial. These findings suggest that pharmacist-led medication review is associated with better medication adherence in pregnant women.

Strengths include the sample size and blinded outcome assessment. Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Residual confounding cannot be excluded. Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.

Conclusions

Pharmacist-led medication review should be considered for pregnant women to improve medication adherence.

Appendices

Ethics approval: IRB-1146.